Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 2001;85:469-473; doi:10.1136/adc.85.6.469
Copyright © 2001 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Arch Dis Child 2001;85:469-473 ( December )

Article

Vigabatrin associated retinal dysfunction in children with epilepsy R Koula, A Chackoa, A Ganeshb, S Bulusuc, K Al Riyamid

a Department of Child Health (Division of Paediatric Neurology), Sultan Qaboos University Hospital, Al Khod, PO Box 38, Zip Code 123, Sultanate of Oman, b Department of Paediatric Ophthalmology, Sultan Qaboos University Hospital, c Department of Clinical Neurophysiology, Sultan Qaboos University Hospital, d Department of Pharmacy and Therapeutics, Sultan Qaboos University Hospital

Correspondence to: Dr Koul rkoul{at}omantel.net.om

Accepted 20 August 2001

BACKGROUND---Recent reports have established that eye changes occur in patients treated with vigabatrin.
AIM---To identify the eye changes associated with vigabatrin, based on a prospective study of children treated for seizures.
METHODS---Twenty nine children on vigabatrin (mainly as add on therapy) were followed up for 6.5 years. Ophthalmic examination was performed before starting treatment and then six monthly in the outpatient clinic.
RESULTS---Twenty one children fulfilled the inclusion criteria. Most had epileptic syndromes with infantile spasms---namely West syndrome, Lennox-Gastaut syndrome, and partial seizures. Vigabatrin dose was 25-114 mg/kg/day (mean 55.8); duration of therapy was 6-85 months (mean 35.7). Four children (19%) developed eye changes (retinal pigmentation, hypopigmented retinal spots, vascular sheathing, and optic atrophy). Visual evoked potentials were abnormal in 16 children. Electroretinography and electro-oculography, which could have picked up eye changes in early stages, were not performed, as this facility was not available.
CONCLUSIONS---Vigabatrin causes eye damage. Most children with epileptic syndromes on vigabatrin cannot complain of their eye problems, hence 3-6 monthly ophthalmic follow up is strongly advised, along with regular electroretinography, electro-oculography, and visual evoked potentials if possible.


Keywords: vigabatrin; epilepsy; retinal dysfunction


© 2001 by Archives of Disease in Childhood

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article


Arch. Dis. Child. 2001 85: 0. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Macleod, S, Appleton, R E (2007). The new antiepileptic drugs. EDUCATION AND PRACTICE 92: 182-188 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs